Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2003
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/24/2003US6583156 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol
06/24/2003US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
06/24/2003US6582609 Recycling 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4 -oxo-3-quinolinecarboxylic acid, sulfate (gatifloxacin sulfate)
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050089A1 Process for the preparation of 4-methyl-7-aminoquinolones
06/19/2003WO2003050078A1 Naphthol derivative and charge control agent comprising the same
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/19/2003US20030114680 3-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)prop-2 -enenitri te is reduced with Raney nickel in the presence of formic acid and water or in the presence of an amine salt of formic acid and an organic acid
06/19/2003US20030114679 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
06/19/2003US20030114671 Corticotropin releasing factor antagonists
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003US20030114435 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2467511A1 Process for the preparation of 4-methyl-7-aminoquinolones
06/18/2003EP1319656A1 A new process for preparing a quinolone-carboxylic acid
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318982A1 Compounds and methods for diagnosing and treating amyloid-related conditions
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003CN1111523C Method for the catalytic production of substituted dipyridyl derivatives
06/17/2003US6579987 Diaryl-enynes
06/17/2003US6579986 Preparation of quinoline-substituted carbonate and carbamate derivatives
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
06/17/2003US6579718 For detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and does not require use of organic solvents
06/17/2003US6579633 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines
06/17/2003CA2040606C Chiral catalysts for reduction of ketones and process for their preparation
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003047749A1 Method for isomerizing allyl alcohols
06/12/2003WO2003047581A1 Acetylene derivatives having mglur 5 antagonistic activity
06/12/2003WO2003047515A2 P2x7 receptor antagonists
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109699 Biopolymers; gene therapy, medical diagnosis
06/12/2003US20030109560 Compounds may be useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR). The compounds exert their effects by modulating the PPAR gamma
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109523 Bicyclic antagonists selective for the alphavbeta3 integrin
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317520A1 Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317411A1 Derivatives of naphthalene with comt inhibiting activity
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003CA2080406C Improved 7-chloroquinaldine synthesis
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003US20030105328 High effectiveness and high oral bioavailability; for example, 6-(4-Acetamidophenyl)-3-isobutyryl-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxoquinoline
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003US20030104063 Low-solubility drug and a matrix combined with a concentration- enhancing polymer. improves stability and/ or enhances concentration
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/04/2003EP1315702A2 Process to produce halo-4-phenoxyquinolines
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
06/04/2003CN1422255A Heterocycle derivatives and drugs
06/04/2003CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
06/04/2003CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides
06/04/2003CN1421437A Bridged peryleneone/quinolindeone
06/04/2003CN1110478C Biocidal benzylbiphenyl derivatives
06/03/2003US6573383 Preparing anhydrous (2R,4S)-4-((3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester by dissolving in heptanes or water and polar solvent and drying
06/03/2003US6573379 Method for preparing halomethyl heterocyclic compounds
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573260 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
05/2003
05/30/2003WO2003043992A1 4-oxoquinoline derivatives
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2002094187A3 Novel use
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100441 Polymerization of olefin
05/28/2003EP1314754A1 Bridged Perinones/Quinophtalones
05/28/2003EP1314726A1 Novel ester or amide derivatives
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 277